breast cancer
Conditions
Interventions
Group P:Propofol 4.0mg/kg/h continuous pumping combined with 2% sevoflurane continuous inhalation
Group R:Remimazolam1.0mg/kg/h continuous pumping combined with 2% sevoflurane continuous inhalation
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Women; Age 18-60 years old; ASA grading I to II; The patient was diagnosed as breast cancer before operation and planned to be operated.
Exclusion criteria
Exclusion criteria: Allergies to drugs in the study protocol; Having sleep disorders requires medication intervention; Taking psychotropic drugs; Preoperative radiotherapy and chemotherapy; Those with severe cardiovascular, liver, kidney, and blood system diseases; BMl>30kg/m2; Inflammatory breast cancer; Previous breast cancer surgery history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| subjective sleep quality on the night of surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative quality of recovery;Withdrawal time and awakening time;The incidence of intraoperative and postoperative adverse events; | — |
Countries
China
Contacts
Public ContactLin Wenqian
Sun Yat-sen University Cancer Center
Outcome results
None listed